Street gushes over Alzheimer’s drug, but some worry about overreaction By: MarketWatch March 20, 2015 at 12:00 PM EDT Analysts split in their reactions to Biogen Idec’s report of test results for its new Alzheimer’s drug. Read More >> Related Stocks: Biogen Idec Eli Lilly Gsk Plc ADR Johnson & Johnson Pfizer